Revenue, Deferred Revenue, Deferred Costs and Other (Tables)

3 Months Ended

Mar. 31, 2021

Revenue, Deferred Revenue, Deferred Costs and Other

Schedule of disaggregation of revenue

The following table presents the Company’s revenues disaggregated by revenue source (in thousands):

	Quarter Ended
	March 31,
	2021		2020
Access Fees Revenue
U.S.	$	350,868	$	107,939
International		37,288		29,114
Total		388,156		137,053
Visit Fee Revenue
U.S.		54,340		43,484
International		122		262
Total		54,462		43,746
Other
U.S.		10,671		0
International		386		0
Total		11,057		0
Total Revenues	$	453,675	$	180,799

Schedule of deferred costs and other

Deferred costs and other as of March 31, 2021 consist of the following (in thousands):

	As of		As of
	March 31,		December 31,
	2021		2020
Deferred device cost, current	$	10,950	$	3,384
Deferred execution credit, current		792		84
Total deferred cost and other, current		11,742		3,468
Deferred device cost, noncurrent		6,190		2,179
Total Deferred cost and other	$	17,932	$	5,647

Deferred costs and other activity are as follows (in thousands):

	Deferred Device Cost		Deferred Execution Credit			Total
Beginning balance as of December 31, 2020	$	5,563	$	84	$	5,647
Additions		13,827		820		14,647
Revenue recognized		0		(112)		(112)
Cost of revenue recognized		(2,250)		0		(2,250)
Ending balance as of March 31, 2021	$	17,140	$	792	$	17,932